Cargando…

Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations

Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous system tumour in adults. It has extremely poor prognosis since the current standard of care, comprising of gross total resection and temozolomide (TMZ) chemoradiotherapy, prolongs survival, but does not provide a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niedbała, Marcin, Malarz, Katarzyna, Sharma, Gitanjali, Kramer-Marek, Gabriela, Kaspera, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060812/ https://www.ncbi.nlm.nih.gov/pubmed/35509452 http://dx.doi.org/10.2147/OTT.S215997

Ejemplares similares

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
por: Szopa, Wojciech, et al.
Publicado: (2017)

Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
por: Sharma, Gitanjali, et al.
Publicado: (2023)

Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
por: Exley, Mark A., et al.
Publicado: (2022)

Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension
por: Gozdz, Agata, et al.
Publicado: (2022)

Immunotherapeutic Approaches for Glioblastoma Treatment
por: Yaghi, Nasser K., et al.
Publicado: (2022)

New Immunotherapeutic Approaches for Glioblastoma
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
por: Dapash, Mark, et al.
Publicado: (2021)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

The role of CMV in glioblastoma and implications for immunotherapeutic strategies
por: Rahman, Maryam, et al.
Publicado: (2018)

Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment
por: Burley, Thomas A., et al.
Publicado: (2018)

Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications
por: Das, Suprava, et al.
Publicado: (2023)

Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies
por: Genoud, Vassilis, et al.
Publicado: (2021)

A Journey on the Skin Microbiome: Pitfalls and Opportunities
por: Pistone, Dario, et al.
Publicado: (2021)

Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas
por: Nesseler, Jean Philippe, et al.
Publicado: (2018)

Restoring the balance: immunotherapeutic combinations for autoimmune disease
por: Smilek, Dawn E., et al.
Publicado: (2014)

Rational combinations of immunotherapeutics that target discrete pathways
por: Spranger, Stefani, et al.
Publicado: (2013)

Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research
por: Khansur, Emaad M, et al.
Publicado: (2018)

UPAR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN RECURRENT GLIOBLASTOMA
por: Maich, William, et al.
Publicado: (2023)

Ultrasound Imaging in Sport-Related Muscle Injuries: Pitfalls and Opportunities
por: Paoletta, Marco, et al.
Publicado: (2021)

Immunomodulation and immunotherapeutics of COVID-19
por: Garg, Sourbh Suren, et al.
Publicado: (2021)

The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls
por: Scholtes, V.P.W, et al.
Publicado: (2011)

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
por: von Gunten, Stephan, et al.
Publicado: (2023)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)

In vitro human gut microbiota fermentation models: opportunities, challenges, and pitfalls
por: Isenring, Julia, et al.
Publicado: (2023)

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
por: Seyfrid, Mathieu, et al.
Publicado: (2022)

Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
por: Pombo Antunes, Ana Rita, et al.
Publicado: (2020)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Practical and Ethical Considerations in Telehealth: Pitfalls and Opportunities
por: Hull, Sarah C., et al.
Publicado: (2022)

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities
por: Lazzari, Chiara, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
por: Brar, Harpinder K., et al.
Publicado: (2022)

Correction: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Publicado: (2022)

Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression
por: Jain, Prateek, et al.
Publicado: (2023)

Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma
por: Wong, Kelvin K., et al.
Publicado: (2016)

Climate and society in long‐term perspective: Opportunities and pitfalls in the use of historical datasets
por: van Bavel, Bas J. P., et al.
Publicado: (2019)

Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches
por: Anghileri, Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mi3cn4tv4i75cf411lanohc27n